M. R. G. Franco

Colistin susceptibility testing and Vitek-2™: is it really useless?

F. Rossi, A. J. da Silva Duarte, J. N. de Almeida, 2018, Diagnostic microbiology and infectious disease.

Rapid molecular test (SeptiFast®) reduced time for adjustment of antibiotic treatment in comparison with conventional blood cultures in critically ill sepsis patients: a randomized controlled clinical trial (preliminary results)

F. Rossi, R. Siciliano, Mirlane Silva dos Santos, 2013, Critical Care.

Genomic Characterization of mcr-1.1-Producing Escherichia coli Recovered From Human Infections in São Paulo, Brazil

J. Setubal, Carlos Morais Piroupo, F. Rossi, 2021, Frontiers in Microbiology.

Metallo‐beta‐lactamases among imipenem‐resistant Pseudomonas aeruginosa in a brazilian university hospital

M. Burattini, F. Rossi, H. Caiaffa-Filho, 2010, Clinics.

Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin.

F. Rossi, M. R. G. Franco, Helenice Rodrigues, 2012, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

The effect of a rapid molecular blood test on the use of antibiotics for nosocomial sepsis: a randomized clinical trial

J. Fukushima, D. De Backer, G. Landoni, 2019, Journal of Intensive Care.

Streptococcus pneumoniae: susceptibility to penicillin and moxifloxacin* , ** Streptococcus pneumoniae: sensibilidade a penicilina e moxifloxacina

F. Rossi, M. R. G. Franco, Denise Andreazzi, 2012 .

OBJECTIVES: To determine the frequency of metallo-b-lactamases among imipenem-resistant Pseudomonas aeruginosa isolates and to compare methods of phenotypic and molecular detection.

M. Burattini, M. R. G. Franco, H. Caiaffa-Filho, 2010 .

Polymyxins susceptibility tests: we need talk about a solution.

Raquel Girardello, Ana Paula Cury, Maria Renata Gomes Franco, 2019, Diagnostic microbiology and infectious disease.